A Phase IIA study using intrathecal treatment of autologous adipose-derived mesenchymal stem cells for amyotrophic lateral sclerosis

Grant Project Details:

Nathan P. Staff, MD, PhD
Mayo Clinic | Rochester, MN
In Process
Explore all RMM grants awarded since inception

Grant timeline: proposal, updates, reports

Grant Location

Mayo Clinic
200 1st St SW
Rochester, MN 55905

Grant Description

The overall objective of this proposal is to conduct a multi-site, placebo-controlled Phase IIA clinical trial to obtain clinical data on the safety, efficacy and mechanism of action of intrathecal injection of adipose-derived mesenchymal stem cells as a regenerative therapy for the treatment of the incurable condition, amyotrophic lateral sclerosis.

Read Staff’s most recent interim report here

Grant Awardee Biography

image of Nathan P. Staff, MD, PhD

Dr. Staff is an Assistant Professor of Neurology at Mayo Clinic.